Literature DB >> 315430

Ligand-activated T cell growth factor-induced proliferation: absorption of T cell growth factor by activated T cells.

G D Bonnard, K Yasaka, D Jacobson.   

Abstract

The fate in culture of the T cell growth factor (TCGF), which is required for continued growth of human cultured T cells (CTC) in vitro, was studied. TCGF activity was stable for 7 days at 37 degrees C. However, it was no longer detectable after incubation with actively growing CTC at 37 degrees C for 3 days. This loss of TCGF activity also occurred quite rapidly and was detectable within 1 hr of incubation of 0.3 ml supernatant with 2 to 5 x 10(7) CTC at 23 degrees C. 2 x 10(8) mononuclear peripheral blood leukocytes were not effective in removing TCGF activity, and incubation with similar numbers of cells from B and T cell lines had no effect. Three-day-old concanavalin A and phytohemagglutinin blasts were very reactive with TCGF, so that 10(7) or 2 x 10(7) cells consistently removed TCGF activity. These experiments suggested specific absorption of TCGF by activated T cells, and led us to develop a model of ligand-activated TCGF-induced proliferation of T cells: Ligands induce production of TCGF by T-producer cells and deliver a first signal to the T-responder cells. This causes a receptor for TCGF to appear on T-responder cells. Only then does TCGF deliver the obligatory second signal that is needed to drive the T-responder cells into proliferation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 315430

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  Cytokine production in patients with inflammatory bowel disease.

Authors:  M Nakamura; H Saito; J Kasanuki; Y Tamura; S Yoshida
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

2.  Limiting dilution analysis (LDA) of cells responding to recombinant interleukin-2 without previous stimulation: evidence that all responding cells are lymphokine-activated potent effectors.

Authors:  H Vie; M Bonneville; P Sondermeyer; J F Moreau; J P Soulillou
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

3.  The glycoprotein nature and biosynthetic relationship of two molecularly distinct species of primate T-cell growth factor.

Authors:  D S Milstone; C W Parker
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857

Review 4.  T cell receptors of autoimmune mice: functional and molecular analysis of novel T cell subsets in C3H-gld/gld mice.

Authors:  K Yui; Y Hashimoto; M I Greene
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

5.  Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans.

Authors:  S Gillis; R Kozak; M Durante; M E Weksler
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

6.  Cultured T lymphocytes cytotoxic for a syngeneic lymphoma: derivation in Con A-conditioned medium and in vivo activity.

Authors:  J Bertoglio; D Gerlier; J P Gerard
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

7.  Human spleen as a source of T cell growth factor.

Authors:  A Moretta; M Colombatti; B Chapuis
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

8.  Antigen-specific human T-cell clones: development of clones requiring HLA-DR-compatible presenting cells for stimulation in presence of antigen.

Authors:  B Sredni; D Volkman; R H Schwartz; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

9.  Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complex.

Authors:  T R Malek; R J Robb; E M Shevach
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

10.  Stimulation of colony formation and growth factor production of human T lymphocytes by wheat germ lectin.

Authors:  A J Ulmer; W Scholz; H D Flad
Journal:  Immunology       Date:  1982-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.